IMG Introduction
IMG Advantages and Opportunities for Taiwan's Biotechnology Industry
 

Advantages:

  1. Active and continuous efforts to build up an attractive investment environment by the government
  2. Large input to investment of up- and mid-stream R&D and infrastructure
  3. Close bond with fast growing Asian markets
  4. Sufficient domestic capital for investing from intensive partners
  5. Solid foundation and experience from the past development of the electronics industry
  6. Proper environment for the development of small- and medium-sized enterprises; and the diligent and aggressive entrepreneurial spirit of the Taiwanese
  7. Ample biotechnology and pharmaceutical professionals based both locally and overseas
  8. Relatively homogenous ethnic Chinese population, ideal for the development of an Asian-prevalent-disease-related biotech industry
  9. Qualified R&D personnel who are capable of establishing a knowledge economy to reflect Taiwan's uniqueness
  10. Advanced traditional agricultural technology to support development of agricultural biotechnology

 

Opportunities:

  1. The key industry in the government's Challenge 2008 six-year national development plan
  2. The listed incentive industry among newly encouraged emerging strategic industries
  3. Rising demand in better living standards in the Asia-Pacific; and growing economy and market for potential development
  4. Increasing number of strategic alliances and technology transfer cases
  5. R&D and precision processing sectors are ready to take advantage of the growing global trend towards outsourcing in the biotechnology industry.
  6. Right timing for endless business opportunities in post human gene decoding
  7. High value-added, long life cycle and value chain of biotechnology; many points of entry available, from R&D to marketing
  8. Flourishing biotechnology R&D service industries (technical evaluation, R&D design, intellectual property services, and start-up incubation services)
  9. 9. Many large-sized high-quality medical centers, providing optimal conditions for undertaking clinical trials
  10. Clear market segmentation from temperate zone products of advanced countries with Taiwan's sub-tropical climate to develop Asian sub-tropical agricultural biotechnology
  11. Plentiful related information aggregated from National Health Insurance program
  12. Diseases associated with a modern sedentary lifestyle, with potential for drug and disease screening technology platforms Objective


經濟部生技醫藥產業發展推動小組全球資訊網
本網站由 經濟部工業局 '生物技術工業發展推動計畫' 專案委辦
電話:02-2655-8133 | 傳真:02-2655-8134
地址:11503台北市南港區園區街三號17樓A室 
 
網頁規劃設計:周國珍先生 indy(at)biopharm.org.tw